Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business Progress
Business Wire•30/10/2026•08:00 ET
0
Key Highlights
- ➤2026 nine-month revenue $244.6M, up 19% year over year
- ➤2026 revenue guidance raised to $325M-$330M
- ➤2026 net product sales guidance narrowed to $310M-$315M
- ➤Nine-month net income $103.5M, up 35% year over year
- ➤Cash, equivalents, restricted cash and investments reached $486.9M
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business Progress
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and nine months ended September 30, 2026 and provided an update on recent business progress.
Get started
Create a free account to read the full story.